|
Post by kimi on Aug 4, 2016 2:30:08 GMT -5
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 4, 2016 2:48:07 GMT -5
Nice find!
|
|
alexer
Lab Rat
Posts: 49
Sentiment: Long
|
Post by alexer on Aug 4, 2016 3:56:09 GMT -5
Awesome! Finally some great news!
|
|
|
Post by dcassidy1618a on Aug 4, 2016 10:14:32 GMT -5
Why hasn't MNKD said anything about it?
|
|
|
Post by mnholdem on Aug 4, 2016 10:22:05 GMT -5
|
|
|
Post by peppy on Aug 4, 2016 10:27:46 GMT -5
This information has been out for a long time... it was posted here last year, I think. This new pediatric trial, MNKD sponsored rather than the canceled Sanofi trial was announced a couple of months ago.(? on the exact time frame) There is a thread somewhere.
|
|
|
Post by dcassidy1618a on Aug 4, 2016 10:45:20 GMT -5
This information has been out for a long time... it was posted here last year, I think. This new pediatric trial, MNKD sponsored rather than the canceled Sanofi trial was announced a couple of months ago.(? on the exact time frame) There is a thread somewhere. Clinicaltrials.gov says only that the Sanofi one was suspended. I don't see any other ongoing trial for afrezza listed. Has MNKD submitted a new trial for FDA approval?
|
|
|
Post by peppy on Aug 4, 2016 10:50:57 GMT -5
This new pediatric trial, MNKD sponsored rather than the canceled Sanofi trial was announced a couple of months ago.(? on the exact time frame) There is a thread somewhere. Clinicaltrials.gov says only that the Sanofi one was suspended. I don't see any other ongoing trial for afrezza listed. Has MNKD submitted a new trial for FDA approval? agreed, the sanofi trial was cancelled. clinicaltrials.gov/ct2/show/NCT02527265
A MNKD pediatric trial was announced to be run with the university of Colorado. It is hopefully recruiting. It was a few weeks ago, the announcement. the link AT THE START OF THE THREaD IS THIS NEW STUDY. Not sure if the study format has been submitted to the FDA for approval. Was it Mike C or Matt. Sports, did it come over twitter? Some one with a better memory, help please.
here it is, scroll down www.ucdenver.edu/Search/Results.aspx?k=afrezza&s=Medicine
Are you interested in trying inhaled insulin for your meal/correction doses?
the blood levels of the study medication (Afrezza®), for blood sugar levels and safety after … Age 4-17 years Type 1 Diabetes for at least 1 year A1C between 7-10% Stable Insulin doses …
www.ucdenver.edu/academics/colleges/medicalschool/research/trials/Lists/Responses/DispForm.aspx?ID=384 - 8/2/2016
|
|
|
Post by sportsrancho on Aug 4, 2016 12:28:16 GMT -5
I did a search on Twitter, I'm still looking for more info.
|
|
|
Post by mnholdem on Aug 4, 2016 13:32:39 GMT -5
|
|
|
Post by otherottawaguy on Aug 4, 2016 15:49:20 GMT -5
From the other board just in case the links are not working:
School of medicine - University of Colorado
The purpose of this study is to evaluate the blood levels of the study medication (Afrezza®), for blood sugar levels and safety after 4 weeks of treatment in children and adolescents between 4-17 years of age with T1DM
Age 4-17 years Type 1 Diabetes for at least 1 year A1C between 7-10% Stable Insulin doses for the past 6 weeks
8/2/2016 Immune System Diseases
|
|
|
Post by sportsrancho on Aug 4, 2016 16:41:17 GMT -5
I did a search on Twitter, I'm still looking for more info. This man writes book for kids that have diabetes and I have talked to him about his next book highlighting Afrezza. Sent him pictures of the dreamboat. And DM Mike his info. It will be great down the road:-) He also has a kids game:
|
|
|
Post by brentie on Aug 4, 2016 16:45:21 GMT -5
|
|
|
Post by goyocafe on Aug 4, 2016 17:28:45 GMT -5
So what do we call the moving parts of this puzzle? 3 Cups And A Ball? Can't call it a lack of transparency, since we don't know the truth behind this, but someone clearly reads this board and reacts to things that we either shouldn't know yet or tries to make it right by getting old stuff out of the way. Who knows, but enjoy the game for now, I guess.
|
|
|
Post by peppy on Aug 4, 2016 17:58:02 GMT -5
From the other board just in case the links are not working: School of medicine - University of Colorado The purpose of this study is to evaluate the blood levels of the study medication (Afrezza®), for blood sugar levels and safety after 4 weeks of treatment in children and adolescents between 4-17 years of age with T1DM Age 4-17 years Type 1 Diabetes for at least 1 year A1C between 7-10% Stable Insulin doses for the past 6 weeks 8/2/2016 Immune System Diseases This showed up in my archive about the time of the Mannkind pediatric trial announcement I think. Mike C retweeted. 05/27/2016
|
|